Rationale, design and conduct of a randomised controlled trial evaluating a primary care-based complex intervention to improve the quality of life of heart failure patients: HICMan (Heidelberg Integrated Case Management)

被引：17
作者：
Peters-Klimm F. [1 ]
Müller-Tasch T. [2 ]
Schellberg D. [2 ]
Gensichen J. [3 ]
Muth C. [3 ]
Herzog W. [2 ]
Szecsenyi J. [1 ]
机构：
[1] Department of General Practice and Health Services Research, University Hospital of Heidelberg, 69115 Heidelberg
[2] Department of Psychosomatic and General Internal Medicine, University of Heidelberg Hospital, 69115 Heidelberg
[3] Institute for General Practice, Chronic Care and Health Services Research University of Frankfurt, 60590 Frankfurt a. M.
来源：
BMC Cardiovascular Disorders | / 7卷 / 1期
关键词：
Congestive Heart Failure; Case Management; Home Visit; Telephone Monitoring; Kansas City Cardiomyopathy Questionnaire;
D O I：
10.1186/1471-2261-7-25
中图分类号：
学科分类号：
摘要：
Background: Chronic congestive heart failure (CHF) is a complex disease with rising prevalence, compromised quality of life (QoL), unplanned hospital admissions, high mortality and therefore high burden of illness. The delivery of care for these patients has been criticized and new strategies addressing crucial domains of care have been shown to be effective on patients' health outcomes, although these trials were conducted in secondary care or in highly organised Health Maintenance Organisations. It remains unclear whether a comprehensive primary care-based case management for the treating general practitioner (GP) can improve patients' QoL. Methods/Design: HICMan is a randomised controlled trial with patients as the unit of randomisation. Aim is to evaluate a structured, standardized and comprehensive complex intervention for patients with CHF in a 12-months follow-up trial. Patients from intervention group receive specific patient leaflets and documentation booklets as well as regular monitoring and screening by a prior trained practice nurse, who gives feedback to the GP upon urgency. Monitoring and screening address aspects of disease-specific self-management, (non)pharmacological adherence and psychosomatic and geriatric comorbidity. GPs are invited to provide a tailored structured counselling 4 times during the trial and receive an additional feedback on pharmacotherapy relevant to prognosis (data of baseline documentation). Patients from control group receive usual care by their GPs, who were introduced to guideline-oriented management and a tailored health counselling concept. Main outcome measurement for patients' QoL is the scale physical functioning of the SF-36 health questionnaire in a 12-month follow-up. Secondary outcomes are the disease specific QoL measured by the Kansas City Cardiomyopathy questionnaire (KCCQ), depression and anxiety disorders (PHQ-9, GAD-7), adherence (EHFScBS and SANA), quality of care measured by an adapted version of the Patient Chronic Illness Assessment of Care questionnaire (PACIC) and NT-proBNP. In addition, comprehensive clinical data are collected about health status, comorbidity, medication and health care utilisation. Discussion: As the targeted patient group is mostly cared for and treated by GPs, a comprehensive primary care-based guideline implementation including somatic, psychosomatic and organisational aspects of the delivery of care (HICMAn) is a promising intervention applying proven strategies for optimal care. Trial registration: Current Controlled Trials ISRCTN30822978. © 2007 Peters-Klimm et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 41 条
[1]  
McMurray J.J., Stewart S., Epidemiology, aetiology, and prognosis of heart failure, Heart, 83, pp. 596-602, (2000)
[2]  
Bursi F., Weston S.A., Redfield M.M., Jacobsen S.J., Pakhomov S., Nkomo V.T., Meverden R.A., Roger V.L., Systolic and diastolic heart failure in the community, JAMA, 296, pp. 2209-2216, (2006)
[3]  
Fischer M., Baessler A., Holmer S.R., Muscholl M., Brockel U., Luchner A., Hense H.W., Doring A., Riegger G., Schunkert H., Epidemiology of left ventricular systolic dysfunction in the general population of Germany: Results of an echocardiographic study of a large population-based sample, Z Kardiol, 92, pp. 294-302, (2003)
[4]  
Shekelle P.G., Rich M.W., Morton S.C., Atkinson C.S., Tu W., Maglione M., Rhodes S., Barrett M., Fonarow G.C., Greenberg B., Heidenreich P.A., Knabel T., Konstam M.A., Steimle A., Warner S.L., Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: A meta-analysis of major clinical trials, J Am Coll Cardiol, 41, pp. 1529-1538, (2003)
[5]  
Stewart S., MacIntyre K., Hole D.J., Capewell S., McMurray J.J., More 'malignant' than cancer? Five-year survival following a first admission for heart failure, Eur J Heart Fail, 3, pp. 315-322, (2001)
[6]  
Muntwyler J., Abetel G., Gruner C., Follath F., One-year mortality among unselected outpatients with heart failure, Eur Heart J, 23, pp. 1861-1866, (2002)
[7]  
Opasich C., Rapezzi C., Lucci D., Gorini M., Pozzar F., Zanelli E., Tavazzi L., Maggioni A.P., Precipitating factors and decision-making processes of short-term worsening heart failure despite "optimal" treatment (from the IN-CHF Registry), Am J Cardiol, 88, pp. 382-387, (2001)
[8]  
Juenger J., Schellberg D., Kraemer S., Haunstetter A., Zugck C., Herzog W., Haass M., Health related quality of life in patients with congestive heart failure: Comparison with other chronic diseases and relation to functional variables, Heart, 87, pp. 235-241, (2002)
[9]  
Konstam V., Salem D., Pouleur H., Kostis J., Gorkin L., Shumaker S., Mottard I., Woods P., Konstam M.A., Yusuf S., Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators, Am J Cardiol, 78, pp. 890-895, (1996)
[10]  
Cohn J.N., Tognoni G., A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure, N Engl J Med, 345, pp. 1667-1675, (2001)
12345